What is the current Oligo Synthesis Service market size?

The Oligo Synthesis Service market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Oligo Synthesis Service market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by key drivers.

What are the key drivers of the Oligo Synthesis Service market?

Key drivers include increasing demand for synthetic oligonucleotides and advancements in genetic engineering technologies.

What are the major challenges facing the Oligo Synthesis Service market?

Challenges include high production costs, stringent regulatory requirements, and limited availability of skilled personnel.

Which regions are leading the Oligo Synthesis Service market?

North America and Europe are regional leaders, accounting for over 60% of the global market share.

Who are the top companies in the Oligo Synthesis Service market?

Top companies include Thermo Fisher Scientific, Sigma-Aldrich, and Agilent Technologies, offering a range of oligo synthesis services.

What are the future opportunities in the Oligo Synthesis Service market?

Future opportunities include increasing adoption in emerging markets, growing demand for personalized medicine, and advancements in CRISPR technology.

How is technology impacting the Oligo Synthesis Service market?

Advances in automation, microfluidics, and artificial intelligence are improving synthesis efficiency, reducing costs, and enhancing future outlook.

What is the current regulatory landscape for the Oligo Synthesis Service market?

The regulatory landscape is governed by guidelines from FDA, EU, and other regulatory bodies, ensuring compliance with GMP and GLP standards.

Oligo Synthesis Service Industry Size, Share & Growth Forecast 2033

Oligo Synthesis Service by Application (Biotech Company, Academic Scientific Research Institution), by Types (Common Primer Synthesis, Modified Primer Synthesis), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $5.59 billion

CAGR: 13.78%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 111

Forecast Period: 2026 - 2033

Market Size: $5.59 billion

CAGR: 13.78%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Oligo Synthesis Service Market Overview

The Oligo Synthesis Service market refers to the industry that provides customized oligonucleotide synthesis services to various sectors, including biotechnology, pharmaceutical, and academic research. As the demand for oligonucleotides continues to rise, the Oligo Synthesis Service market size is expected to reach $1.3 billion by 2026, with a growth outlook that is optimistic and a market forecast that indicates a significant expansion of the industry. The scope of this market encompasses various services, including DNA synthesis, RNA synthesis, and gene synthesis, which are crucial for advancements in genomics, gene editing, and synthetic biology.

Loading chart…

The growth forecast for the Oligo Synthesis Service market indicates a compound annual growth rate (CAGR) of 10.5% from 2026 to 2033, driven by macro drivers such as advancements in gene editing technologies, increasing demand for personalized medicine, and rising investments in biotechnology research. Key forces shaping the industry include technology shifts towards automated synthesis platforms, regulatory developments in genetic engineering, and changing consumer behavior towards precision medicine. The largest region in the Oligo Synthesis Service market is North America, while the fastest-growing region is Asia-Pacific, driven by emerging economies such as China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	5.59 billion
Revenue forecast in 2033	9.75 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Billion and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; GENEWIZ; Genscript; Abace Biotechnology; Tsingke; Sangon Biotech; Shanghai Genecore BioTechnologies; Atantares; Wuhan GeneCreate Biological Engineering; Beyotime; General Biol; Beijing Biomed; Takara; Biosune; Beijing Dingguo Changsheng Biotechnology; Integrated DNA Technologies (IDT); Cusabio; Macrogen Europe BV; Synbio Technologies
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Oligo Synthesis Service market is poised for significant growth, driven by various factors. The market dynamics are influenced by several key elements that impact the Oligo Synthesis Service market size and growth forecast.

Growth Drivers2 items

Advances in genomics and proteomics research are driving the demand for oligo synthesis services, as these services enable the rapid and cost-effective production of high-quality oligonucleotides.

The increasing adoption of next-generation sequencing technologies is also fueling the growth of the Oligo Synthesis Service market, as these technologies require high-quality oligonucleotides for library preparation and sequencing.

Restraints2 items

The high cost of oligo synthesis equipment and reagents is a significant restraint for the Oligo Synthesis Service market, as it limits the adoption of these services among small and medium-sized research institutions.

The lack of standardization in oligo synthesis services is also a challenge, as it can lead to variability in the quality of oligonucleotides and make it difficult for researchers to compare results.

Opportunities2 items

The growing demand for personalized medicine and precision diagnostics is creating opportunities for the Oligo Synthesis Service market, as oligo synthesis services can be used to develop customized diagnostic tests and therapies.

The increasing use of CRISPR-Cas9 gene editing technology is also creating opportunities for the Oligo Synthesis Service market, as this technology requires high-quality oligonucleotides for gene editing applications.

Challenges2 items

The Oligo Synthesis Service market faces challenges related to regulatory compliance, as the production and use of oligonucleotides are subject to various regulations and guidelines.

The market also faces challenges related to intellectual property protection, as the development and use of oligonucleotides can involve complex intellectual property issues.

Market Segmentation

Loading chart…

The Oligo Synthesis Service market can be segmented based on Application, which refers to the various uses of oligo synthesis services across different industries. This segmentation category contributes to the overall market size by highlighting the diverse range of applications that drive demand for these services. The application segment includes subtypes such as research and development, diagnostics, and therapeutics, each with its own unique requirements and growth prospects. Understanding the application segment is crucial for Oligo Synthesis Service segmentation as it helps identify emerging trends and opportunities in the market.

The Types segment is another critical category in the Oligo Synthesis Service market, encompassing various subtypes such as DNA oligos, RNA oligos, and modified oligos. Each subtype has its own distinct characteristics, advantages, and limitations, catering to specific needs of researchers, diagnostic laboratories, and pharmaceutical companies. The types segment plays a significant role in determining the overall market size, as it directly influences the demand for oligo synthesis services. By analyzing the types segment, industry stakeholders can gain valuable insights into the market taxonomy and make informed decisions to drive business growth.

Oligo Synthesis Service Segmentation Breakdown6 items

Application

Biotech Company

Academic Scientific Research Institution

Types

Common Primer Synthesis

Modified Primer Synthesis

Regional Insights

Loading chart…

The Oligo Synthesis Service market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the market share, and North America being the fastest-growing region. Key drivers for North America include increasing adoption of oligo synthesis services in the pharmaceutical and biotechnology industries, favorable policies supporting research and development, and significant investments in the life sciences sector.

In Europe, key drivers include a mature ecosystem with a high concentration of pharmaceutical and biotechnology companies, a strong infrastructure supporting research and development, and a large demographic with a high demand for oligo synthesis services. Asia Pacific is driven by a large and growing demographic, increasing adoption of oligo synthesis services in emerging economies, and significant investments in the life sciences sector. Latin America and Middle East & Africa are driven by increasing adoption of oligo synthesis services, favorable policies supporting research and development, and growing infrastructure supporting the life sciences sector.

The regional forecast indicates that North America will experience the highest growth rate, driven by increasing demand for oligo synthesis services in the pharmaceutical and biotechnology industries. The Oligo Synthesis Service market growth is expected to be driven by increasing adoption of oligo synthesis services, favorable policies supporting research and development, and significant investments in the life sciences sector across all regions.

Competitive Landscape

The Oligo Synthesis Service market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, and product innovation. The Oligo Synthesis Service competitive landscape is driven by key competitive levers, including certifications and regulatory approvals. Global players tend to have an advantage in terms of economies of scale and distribution networks, while local companies focus on regional expansion and customization to differentiate themselves.

Companies in the Oligo Synthesis Service market employ various strategies to differentiate themselves, including M&A, partnerships, and product launches. Common differentiation strategies include technology, service model, and channel strength, as well as customization and cost advantages. However, companies face challenges such as margin pressure, compliance costs, and commoditization, which can erode profitability. To stay competitive, companies must focus on innovation, localization, and strategic partnerships to mitigate these risks.

Thermo Fisher Scientific: regional expansion

GENEWIZ: premium pricing

Genscript: innovation pipeline

Abace Biotechnology: local manufacturing

Tsingke: OEM tie-ups

Sangon Biotech: vertical integration

Key Oligo Synthesis Service Companies19 items

Thermo Fisher Scientific

GENEWIZ

Genscript

Abace Biotechnology

Tsingke

Sangon Biotech

Shanghai Genecore BioTechnologies

Atantares

Wuhan GeneCreate Biological Engineering

Beyotime

General Biol

Beijing Biomed

Takara

Biosune

Beijing Dingguo Changsheng Biotechnology

Integrated DNA Technologies (IDT)

Cusabio

Macrogen Europe BV

Synbio Technologies

Market Ecosystem

The Oligo Synthesis Service ecosystem encompasses a network of participants that create and capture value across the upstream, midstream, and downstream segments. This ecosystem includes technology providers, integrators, channels, and end users, all of which contribute to the development, production, and delivery of oligo synthesis services. The value chain analysis of this ecosystem reveals the complex relationships and interactions between these participants, highlighting how value is created and captured.

Raw material suppliers — provide chemical precursors

Technology providers — develop synthesis platforms

System integrators — design and optimize synthesis workflows

Service providers — offer synthesis and purification services

Distributors — manage logistics and supply chain operations

End users — research institutions and pharmaceutical companies

Regulators — establish standards and guidelines for service quality

The flow of value in the Oligo Synthesis Service ecosystem is influenced by control points, such as regulatory bodies and large research institutions, which can affect adoption rates and service quality standards. Dependency risks, including input constraints and approval processes, can also impact the ecosystem. Furthermore, switching costs and partnerships between service providers and end users can create barriers to entry and affect the overall dynamics of the ecosystem, which may differ by region due to varying regulatory environments and market demands.

Recent Industry Insights

The Oligo Synthesis Service industry has witnessed significant developments over the last 12-18 months, shaping the Oligo Synthesis Service industry trends. Recent partnerships between key players have focused on enhancing service capabilities and expanding global reach. Notable mergers and acquisitions have also led to increased consolidation in the market, driving growth and innovation. Furthermore, several companies have launched new products and technologies, improving synthesis efficiency and accuracy. Regulatory changes have emphasized the need for high-quality services, prompting companies to invest in research and development. A shift in consumer trends towards personalized medicine and genetic research has also fueled demand for customized oligo synthesis services, with several companies securing funding rounds to support expansions and advancements in this area.

Analyst Overview

As the Lead Analyst for this study, I provide a comprehensive overview of the Oligo Synthesis Service market. The market attractiveness is high due to increasing demand from the pharmaceutical and biotechnology sectors. Competitive intensity is moderate, with key players competing on the basis of service quality, pricing, and innovation. The long-term outlook for the Oligo Synthesis Service market outlook is positive, driven by advancements in genetic research and the growing need for customized oligonucleotides.

The innovation landscape is dynamic, with ongoing research and development focused on improving synthesis efficiency, yield, and purity. Demand-supply balance is stable, with key players expanding their capacity to meet the growing demand. However, key risk factors include regulatory changes and supply chain disruptions, which could impact market growth. Overall, the market is expected to experience steady growth, driven by increasing adoption in various end-use industries.

11 items

1. Executive Summary

2. Oligo Synthesis Service Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Oligo Synthesis Service Market Outlook & Forecast (2021-2033) Value (USD Billion)

6.1. Global Oligo Synthesis Service Market Revenue (USD Billion) and CAGR (%) by Application (2020-2032)

6.1.1. Biotech Company

6.1.2. Academic Scientific Research Institution

6.2. Global Oligo Synthesis Service Market Revenue (USD Billion) and CAGR (%) by Types (2020-2032)

6.2.1. Common Primer Synthesis

6.2.2. Modified Primer Synthesis

6.3. Global Oligo Synthesis Service Market Revenue (USD Billion) and CAGR (%) by Region (2020-2032)

7. Global Oligo Synthesis Service Market Breakdown Data By Value (USD Billion) (2020-2032)

7.1. Global Oligo Synthesis Service Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Billion) (2020-2032) By Country

7.2.2. North America Value (USD Billion) (2020-2032) by Application

7.2.3. North America Value (USD Billion) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Billion) (2020-2032) By Country

7.3.2. South America Value (USD Billion) (2020-2032) by Application

7.3.3. South America Value (USD Billion) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Billion) (2020-2032) By Country

7.4.2. Europe Value (USD Billion) (2020-2032) by Application

7.4.3. Europe Value (USD Billion) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Billion) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Billion) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Billion) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Billion) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Billion) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Billion) (2020-2032) by Types

8. Global Oligo Synthesis Service Market Competition by Key Manufacturers

8.1. Global Oligo Synthesis Service Revenue (USD Billion) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Oligo Synthesis Service: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Fisher Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. GENEWIZ

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Genscript

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Abace Biotechnology

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Tsingke

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Sangon Biotech

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Shanghai Genecore BioTechnologies

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Atantares

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Wuhan GeneCreate Biological Engineering

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Beyotime

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. General Biol

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Beijing Biomed

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Takara

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Biosune

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Beijing Dingguo Changsheng Biotechnology

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Integrated DNA Technologies (IDT)

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Cusabio

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Macrogen Europe BV

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Synbio Technologies

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Oligo Synthesis Service Market

Figure 4: Global Oligo Synthesis Service Market: Drivers

Figure 5: Global Oligo Synthesis Service Market: Challenges

Figure 6: Global Oligo Synthesis Service Market: Trends

Figure 7: Global Oligo Synthesis Service Market: Opportunity

Figure 8: Global Oligo Synthesis Service Market: Restraint

Figure 9: Global Oligo Synthesis Service Market: Porter's Five Forces

Figure 10: Global Market Value (USD Billion) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Billion) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Oligo Synthesis Service Market Value (USD Billion) By Region

Figure 15: Global Oligo Synthesis Service Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Billion) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Billion) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Oligo Synthesis Service Market Value (USD Billion) By Region

Figure 23: Global Oligo Synthesis Service Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

91 items

Table 1: Market Segmentation Analysis

Table 2: Global Oligo Synthesis Service Revenue (USD Billion) And Cagr (%) By Application (2020-2032)

Table 3: Global Oligo Synthesis Service Revenue (USD Billion) And Cagr (%) By Types (2020-2032)

Table 4: Global Oligo Synthesis Service Revenue (USD Billion) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Billion) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Billion) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Oligo Synthesis Service Market Value (USD Billion) By Region

Table 10: Global Oligo Synthesis Service Market Share (%) By Region

Table 11: North America Market Value (USD Billion) (2020-2024) By Country

Table 12: North America Market Value (USD Billion) (2020-2024) By Application

Table 13: North America Market Value (USD Billion) (2020-2024) By Types

Table 14: Europe Market Value (USD Billion) (2020-2024) By Country

Table 15: Europe Market Value (USD Billion) (2020-2024) By Application

Table 16: Europe Market Value (USD Billion) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Billion) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Billion) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Billion) (2020-2024) By Types

Table 20: South America Market Value (USD Billion) (2020-2024) By Country

Table 21: South America Market Value (USD Billion) (2020-2024) By Application

Table 22: South America Market Value (USD Billion) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Billion) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Billion) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Billion) (2020-2024) By Types

Table 26: Global Oligo Synthesis Service Market Revenue (USD Billion) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Oligo Synthesis Service Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Oligo Synthesis Service Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermo Fisher Scientific Basic Information And Sales Area

Table 31: Thermo Fisher Scientific. Products Portfolio

Table 32: GENEWIZ Basic Information And Sales Area

Table 33: GENEWIZ. Products Portfolio

Table 34: Genscript Basic Information And Sales Area

Table 35: Genscript. Products Portfolio

Table 36: Abace Biotechnology Basic Information And Sales Area

Table 37: Abace Biotechnology. Products Portfolio

Table 38: Tsingke Basic Information And Sales Area

Table 39: Tsingke. Products Portfolio

Table 40: Sangon Biotech Basic Information And Sales Area

Table 41: Sangon Biotech. Products Portfolio

Table 42: Shanghai Genecore BioTechnologies Basic Information And Sales Area

Table 43: Shanghai Genecore BioTechnologies. Products Portfolio

Table 44: Atantares Basic Information And Sales Area

Table 45: Atantares. Products Portfolio

Table 46: Wuhan GeneCreate Biological Engineering Basic Information And Sales Area

Table 47: Wuhan GeneCreate Biological Engineering. Products Portfolio

Table 48: Beyotime Basic Information And Sales Area

Table 49: Beyotime. Products Portfolio

Table 50: General Biol Basic Information And Sales Area

Table 51: General Biol. Products Portfolio

Table 52: Beijing Biomed Basic Information And Sales Area

Table 53: Beijing Biomed. Products Portfolio

Table 54: Takara Basic Information And Sales Area

Table 55: Takara. Products Portfolio

Table 56: Biosune Basic Information And Sales Area

Table 57: Biosune. Products Portfolio

Table 58: Beijing Dingguo Changsheng Biotechnology Basic Information And Sales Area

Table 59: Beijing Dingguo Changsheng Biotechnology. Products Portfolio

Table 60: Integrated DNA Technologies (IDT) Basic Information And Sales Area

Table 61: Integrated DNA Technologies (IDT). Products Portfolio

Table 62: Cusabio Basic Information And Sales Area

Table 63: Cusabio. Products Portfolio

Table 64: Macrogen Europe BV Basic Information And Sales Area

Table 65: Macrogen Europe BV. Products Portfolio

Table 66: Synbio Technologies Basic Information And Sales Area

Table 67: Synbio Technologies. Products Portfolio

Table 68: Global Market Value (USD Billion) (2025-2032) By Application

Table 69: Global Market Share (%) By Application (2032)

Table 70: Global Market Value (USD Billion) (2025-2032) By Types

Table 71: Global Market Share (%) By Types (2032)

Table 72: Global Oligo Synthesis Service Market Value (USD Billion) By Region

Table 73: Global Oligo Synthesis Service Market Share (%) By Region (2025-2032)

Table 74: North America Market Value (USD Billion) (2025-2032) By Country

Table 75: North America Market Value (USD Billion) (2025-2032) By Application

Table 76: North America Market Value (USD Billion) (2025-2032) By Types

Table 77: Europe Market Value (USD Billion) (2025-2032) By Country

Table 78: Europe Market Value (USD Billion) (2025-2032) By Application

Table 79: Europe Market Value (USD Billion) (2025-2032) By Types

Table 80: Asia Pacific Market Value (USD Billion) (2025-2032) By Country

Table 81: Asia Pacific Market Value (USD Billion) (2025-2032) By Application

Table 82: Asia Pacific Market Value (USD Billion) (2025-2032) By Types

Table 83: South America Market Value (USD Billion) (2025-2032) By Country

Table 84: South America Market Value (USD Billion) (2025-2032) By Application

Table 85: South America Market Value (USD Billion) (2025-2032) By Types

Table 86: Middle East & Africa Market Value (USD Billion) (2025-2032) By Country

Table 87: Middle East & Africa Market Value (USD Billion) (2025-2032) By Application

Table 88: Middle East & Africa Market Value (USD Billion) (2025-2032) By Types

Table 89: Research Programs/Design For This Report

Table 90: Key Data Information From Secondary Sources

Table 91: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Oligo Synthesis Service Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	5.59 billion
Revenue forecast in 2033	9.75 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Billion and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; GENEWIZ; Genscript; Abace Biotechnology; Tsingke; Sangon Biotech; Shanghai Genecore BioTechnologies; Atantares; Wuhan GeneCreate Biological Engineering; Beyotime; General Biol; Beijing Biomed; Takara; Biosune; Beijing Dingguo Changsheng Biotechnology; Integrated DNA Technologies (IDT); Cusabio; Macrogen Europe BV; Synbio Technologies
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

The Oligo Synthesis Service market faces challenges related to regulatory compliance, as the production and use of oligonucleotides are subject to various regulations and guidelines.

The market also faces challenges related to intellectual property protection, as the development and use of oligonucleotides can involve complex intellectual property issues.

Market Segmentation

Loading chart…

Oligo Synthesis Service Segmentation Breakdown6 items

Application

Biotech Company

Academic Scientific Research Institution

Types

Common Primer Synthesis

Modified Primer Synthesis

Regional Insights

Loading chart…

Competitive Landscape

Thermo Fisher Scientific: regional expansion

GENEWIZ: premium pricing

Genscript: innovation pipeline

Abace Biotechnology: local manufacturing

Tsingke: OEM tie-ups

Sangon Biotech: vertical integration

Key Oligo Synthesis Service Companies19 items

Thermo Fisher Scientific

GENEWIZ

Genscript

Abace Biotechnology

Tsingke

Sangon Biotech

Shanghai Genecore BioTechnologies

Atantares

Wuhan GeneCreate Biological Engineering

Beyotime

General Biol

Beijing Biomed

Takara

Biosune

Beijing Dingguo Changsheng Biotechnology

Integrated DNA Technologies (IDT)

Cusabio

Macrogen Europe BV

Synbio Technologies

Market Ecosystem

Raw material suppliers — provide chemical precursors

Technology providers — develop synthesis platforms

System integrators — design and optimize synthesis workflows

Service providers — offer synthesis and purification services

Distributors — manage logistics and supply chain operations

End users — research institutions and pharmaceutical companies

Regulators — establish standards and guidelines for service quality

Recent Industry Insights

Analyst Overview

Table of Contents